Tyler P Johnson, MD
Hematology/Oncology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Johnson’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A114397 · Current
Licensed to practise in California · since 2010 · expires 2028-10-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$71,662
Medicare paid this office $71,662 for 166 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 83 | $37,253 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $14,488 | $106 |
| Long return visit (40+ min) | 30 | $5,294 | $126 |
| Return visit (30+ min) | 34 | $4,363 | $121 |
| New patient visit (60+ min) | 12 | $2,495 | $208 |
See all 7 services
| Long return visit (40+ min) | 83 | $37,253 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $14,488 | $106 |
| Long return visit (40+ min) | 30 | $5,294 | $126 |
| Return visit (30+ min) | 34 | $4,363 | $121 |
| New patient visit (60+ min) | 12 | $2,495 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $2,124 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,022 | $156 |
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 11% · Women 49% · Also on Medicaid 30% · Health risk score 2.78. Sicker patients than 9 in 10 peers; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 74% · Cancer 58% · Diabetes 33% · Coronary heart disease 30% · Chronic kidney disease 26% · Heart failure 22% · Atrial fibrillation 20% · COPD 19% · Depression 19% · Stroke 13% · Dementia 11%.
The office billed $344,435, Medicare allowed $91,440 and paid $71,662; for 524 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 166 | 524 | 74 | 2.78 | $344,435 | $71,662 |
| 2023 | 176 | 602 | 74 | 2.53 | $352,171 | $67,986 |
| 2022 | 203 | 628 | 73 | 2.66 | $368,342 | $67,796 |
| 2021 | 216 | 716 | 72 | 2.32 | $466,578 | $86,442 |
| 2020 | 197 | 677 | 71 | 2.40 | $301,209 | $66,548 |
| 2019 | 178 | 586 | 72 | 2.76 | $116,578 | $53,473 |
| 2018 | 179 | 562 | 71 | 2.17 | $122,423 | $53,488 |
| 2017 | 109 | 384 | 72 | 2.38 | $107,215 | $36,936 |
| 2016 | 58 | 147 | 72 | 1.92 | $52,527 | $16,065 |
| 2013 | 34 | 116 | 74 | 2.93 | $31,000 | $8,695 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 108 | $33,537 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $10,531 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $8,026 | $73 |
| Return visit (30+ min) | 54 | $5,781 | $89 |
| New patient visit (60+ min) | 20 | $3,340 | $167 |
| Hospital discharge day management, more than 30 minutes | 22 | $2,356 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,315 | $120 |
2022: 8 services
| Long return visit (40+ min) | 100 | $23,948 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $14,869 | $94 |
| Return visit (30+ min) | 93 | $14,470 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,698 | $181 |
| New patient visit (60+ min) | 21 | $3,143 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,198 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,837 | $122 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,371 | $98 |
2021: 7 services
| Long return visit (40+ min) | 129 | $46,148 | $133 |
| Return visit (30+ min) | 89 | $12,107 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $10,920 | $95 |
| New patient visit (60+ min) | 59 | $10,150 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,377 | $188 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,526 | $102 |
| Short return visit (20+ min) | 15 | $990 | $62 |
2020: 7 services
| Return visit (30+ min) | 84 | $16,458 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $14,340 | $98 |
| Long return visit (40+ min) | 70 | $14,008 | $105 |
| New patient visit (60+ min) | 61 | $9,560 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $5,502 | $190 |
| Hospital discharge day management, more than 30 minutes | 28 | $3,050 | $102 |
| Short return visit (20+ min) | 22 | $1,097 | $46 |
2019: 6 services
| Return visit (30+ min) | 103 | $19,154 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $11,414 | $94 |
| Long return visit (40+ min) | 50 | $7,572 | $101 |
| New patient visit (60+ min) | 51 | $7,552 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,487 | $184 |
| Hospital discharge day management, more than 30 minutes | 20 | $1,983 | $99 |
2018: 6 services
| Return visit (30+ min) | 86 | $16,336 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $12,908 | $94 |
| New patient visit (60+ min) | 71 | $10,604 | $149 |
| Long return visit (40+ min) | 44 | $5,886 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,703 | $181 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,675 | $99 |
2017: 5 services
| Long return visit (40+ min) | 53 | $10,897 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $7,946 | $93 |
| Return visit (30+ min) | 38 | $7,497 | $70 |
| New patient visit (60+ min) | 36 | $5,166 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,901 | $181 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $5,833 | $93 |
| New patient visit (60+ min) | 26 | $3,893 | $150 |
| Long return visit (40+ min) | 16 | $3,865 | $99 |
2013: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $4,814 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,414 | $121 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,171 | $65 |
Medicaid work
$7,713 in 2024
Medicaid paid $7,713 for 133 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 93 | $4,541 |
| Long return visit (40+ min) | 40 | $3,172 |
| 2024 | 133 | 2 | 17 | $7,713 |
| 2023 | 192 | 2 | 24 | $10,992 |
| 2022 | 30 | 2 | 14 | $1,282 |
| 2021 | 141 | 1 | 17 | $9,024 |
| 2020 | 45 | 1 | 14 | $1,460 |
| 2019 | 140 | 1 | 17 | $5,539 |
| 2018 | 98 | 1 | 16 | $3,954 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 163 | $9,923 |
| Return visit (30+ min) | 29 | $1,069 |
2022
| Long return visit (40+ min) | 16 | $956 |
| Return visit (30+ min) | 14 | $326 |
2021
| Long return visit (40+ min) | 141 | $9,024 |
2020
| Return visit (30+ min) | 45 | $1,460 |
2019
| Return visit (30+ min) | 140 | $5,539 |
2018
| Return visit (30+ min) | 98 | $3,954 |
Drugs they prescribed that Part D paid
$9,960
Pharmacies billed $9,960 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 108) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
97 generic and 11 brand-name prescriptions · $9,960 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Loperamide | 16 | $207 | $13 |
| Potassium Chloride | 15 | $144 | $10 |
| Prochlorperazine Maleate | 11 | $122 | $11 |
| Ondansetron | 13 | $82 | $6 |
Year by year
| 2024 | 108 | 37 | 0% (0) | 10% | $9,960 |
| 2023 | 118 | 42 | None | None | $17,997 |
| 2022 | 122 | 33 | 0% (0) | None | $36,057 |
| 2021 | 74 | 32 | 0% (0) | 23% | $5,586 |
| 2020 | 133 | 32 | 0% (0) | 32% | $17,146 |
| 2019 | 200 | 46 | None | 16% | $81,576 |
| 2018 | 157 | 50 | None | 12% | $51,133 |
| 2017 | 122 | 27 | None | 20% | $213,630 |
| 2016 | 42 | 14 | 0% (0) | None | $23,959 |
| 2013 | 54 | 16 | None | None | $6,261 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Prochlorperazine Maleate | 24 | $335 | $14 |
| Ondansetron | 16 | $243 | $15 |
2022: 3 drugs
| Eliquis | 15 | $8,871 | $591 |
| Ondansetron | 11 | $375 | $34 |
| Prochlorperazine Maleate | 11 | $147 | $13 |
2020: 4 drugs
| Eliquis | 11 | $7,442 | $677 |
| Sodium Chloride | 17 | $414 | $24 |
| Ondansetron | 13 | $318 | $24 |
| Prochlorperazine Maleate | 18 | $210 | $12 |
2019: 2 drugs
| Prochlorperazine Maleate | 47 | $486 | $10 |
| Ondansetron | 36 | $412 | $11 |
2018: 3 drugs
| Imatinib Mesylate | 12 | $10,990 | $916 |
| Ondansetron | 44 | $859 | $20 |
| Prochlorperazine Maleate | 31 | $195 | $6 |
2017: 4 drugs
| Nexavar | 14 | $120,254 | $8,590 |
| Imatinib Mesylate | 12 | $54,849 | $4,571 |
| Ondansetron | 23 | $292 | $13 |
| Prochlorperazine Maleate | 20 | $130 | $7 |
Money from drug and device companies
$64 in 2025
| 2025 | 2 | 2 | None | $64 |
| 2023 | 1 | 1 | None | $134 |
| 2021 | 1 | 1 | $2,380 | $2,380 |
| 2019 | 1 | 3 | None | $221 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $34 | 1 payment
|
| United Therapeutics | Tyvaso | $30 | 1 payment
|
See all 2 published payments
| United Therapeutics | Meals · 2025-04-08 | Tyvaso | $30 |
| Astellas Pharma US | Meals · 2025-02-25 | Veozah | $34 |
See earlier years (2023, 2021, 2019)
2023: $134
| Jazz Pharmaceuticals | Xywav | $134 | 1 payment
|
2021: $2,380
| Servier Pharmaceuticals | Tibsovo | $2,380 | 1 payment
|
2019: $221
| Wright Medical Technology | Blueprint Psi System | $221 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689945362
- Licence
- CA A114397California A114397: Current · expires 2028-10-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2009
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Medical oncology (207RX0202X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-01-26
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 875 Blake Wilbur Dr, Palo Alto, CA, 94304